ERBB2 and breast cancer: We also showed that pharmacological inhibition of NO in normal mammary glands of wild-type mice induced the formation of precancerous lesions that highly expressed HER2, indicating a potential pathogenic relevance of NO inhibition to HER2+ breast cancer (12).